Institute of Biomedicine, University of Helsinki, Helsinki, Finland.
PLoS One. 2011 Apr 26;6(4):e19161. doi: 10.1371/journal.pone.0019161.
After severe myocardial infarction (MI), heart failure results from ischemia, fibrosis, and remodeling. A promising therapy to enhance cardiac function and induce therapeutic angiogenesis via a paracrine mechanism in MI is myoblast sheet transplantation. We hypothesized that in a rat model of MI-induced chronic heart failure, this therapy could be further improved by overexpression of the antiapoptotic, antifibrotic, and proangiogenic hepatocyte growth factor (HGF) in the myoblast sheets. We studied the ability of wild type (L6-WT) and human HGF-expressing (L6-HGF) L6 myoblast sheet-derived paracrine factors to stimulate cardiomyocyte, endothelial cell, or smooth muscle cell migration in culture. Further, we studied the autocrine effect of hHGF-expression on myoblast gene expression profiles by use of microarray analysis. We induced MI in Wistar rats by left anterior descending coronary artery (LAD) ligation and allowed heart failure to develop for 4 weeks. Thereafter, we administered L6-WT (n = 15) or L6-HGF (n = 16) myoblast sheet therapy. Control rats (n = 13) underwent LAD ligation and rethoracotomy without therapy, and five rats underwent a sham operation in both surgeries. We evaluated cardiac function with echocardiography at 2 and 4 weeks after therapy, and analyzed cardiac angiogenesis and left ventricular architecture from histological sections at 4 weeks. Paracrine mediators from L6-HGF myoblast sheets effectively induced migration of cardiac endothelial and smooth muscle cells but not cardiomyocytes. Microarray data revealed that hHGF-expression modulated myoblast gene expression. In vivo, L6-HGF sheet therapy effectively stimulated angiogenesis in the infarcted and non-infarcted areas. Both L6-WT and L6-HGF therapies enhanced cardiac function and inhibited remodeling in a similar fashion. In conclusion, L6-HGF therapy effectively induced angiogenesis in the chronically failing heart. Cardiac function, however, was not further enhanced by hHGF expression.
在严重心肌梗死(MI)后,心力衰竭是由缺血、纤维化和重塑引起的。通过旁分泌机制增强心肌功能并诱导 MI 治疗性血管生成的一种有前途的疗法是成肌细胞片移植。我们假设,在 MI 诱导的慢性心力衰竭大鼠模型中,通过在成肌细胞片中过度表达抗凋亡、抗纤维化和促血管生成的肝细胞生长因子(HGF),可以进一步改善这种疗法。我们研究了野生型(L6-WT)和成肌细胞片衍生的旁分泌因子对培养中的心肌细胞、内皮细胞或平滑肌细胞迁移的刺激能力。此外,我们还通过微阵列分析研究了 hHGF 表达对成肌细胞基因表达谱的自分泌作用。我们通过左前降支(LAD)结扎诱导 Wistar 大鼠发生 MI,并允许心力衰竭发展 4 周。此后,我们给予 L6-WT(n = 15)或 L6-HGF(n = 16)成肌细胞片治疗。对照大鼠(n = 13)接受 LAD 结扎和再开胸手术但无治疗,5 只大鼠接受两次手术的假手术。我们在治疗后 2 周和 4 周时通过超声心动图评估心功能,并在 4 周时从组织学切片分析心脏血管生成和左心室结构。L6-HGF 成肌细胞片的旁分泌介质有效诱导心脏内皮和平滑肌细胞的迁移,但不诱导心肌细胞的迁移。微阵列数据显示,hHGF 表达调节成肌细胞基因表达。在体内,L6-HGF 片治疗有效刺激梗死区和非梗死区的血管生成。L6-WT 和 L6-HGF 治疗均以相似的方式增强心功能并抑制重塑。总之,L6-HGF 治疗有效诱导慢性心力衰竭中的血管生成。然而,hHGF 表达并未进一步增强心功能。